117 related articles for article (PubMed ID: 19428600)
21. Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C.
Wedemeyer H; Schuller E; Schlaphoff V; Stauber RE; Wiegand J; Schiefke I; Firbas C; Jilma B; Thursz M; Zeuzem S; Hofmann WP; Hinrichsen H; Tauber E; Manns MP; Klade CS
Vaccine; 2009 Aug; 27(37):5142-51. PubMed ID: 19559112
[TBL] [Abstract][Full Text] [Related]
22. Virological relapse in chronic hepatitis C.
Poordad FF; Flamm SL
Antivir Ther; 2009; 14(3):303-13. PubMed ID: 19474464
[TBL] [Abstract][Full Text] [Related]
23. GI-5005, a yeast vector vaccine expressing an NS3-core fusion protein for chronic HCV infection.
Habersetzer F; Baumert TF; Stoll-Keller F
Curr Opin Mol Ther; 2009 Aug; 11(4):456-62. PubMed ID: 19649991
[TBL] [Abstract][Full Text] [Related]
24. Clinical use of interferon in hepatitis B and C.
Schalm SW
Verh K Acad Geneeskd Belg; 2009; 71(1-2):87-99. PubMed ID: 19739400
[TBL] [Abstract][Full Text] [Related]
25. Distinct susceptibility of dendritic cell subsets to hepatitis C virus infection: a plausible mechanism of dendritic cell dysfunction.
Kanto T; Hayashi N
J Gastroenterol; 2004 Aug; 39(8):811-2. PubMed ID: 15338382
[No Abstract] [Full Text] [Related]
26. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.
Oliviero B; Varchetta S; Paudice E; Michelone G; Zaramella M; Mavilio D; De Filippi F; Bruno S; Mondelli MU
Gastroenterology; 2009 Sep; 137(3):1151-60, 1160.e1-7. PubMed ID: 19470388
[TBL] [Abstract][Full Text] [Related]
27. Conservation of hepatitis C virus nonstructural protein 3 amino acid sequence in viral isolates during liver transplantation.
Mello IM; Thumann C; Schvoerer E; Soulier E; Pinho JR; Silvestre DA; Queiroz AT; Wolf P; Baumert TF; Keller FS; Pereira CA
J Viral Hepat; 2009 Oct; 16(10):732-7. PubMed ID: 19486468
[TBL] [Abstract][Full Text] [Related]
28. Non-organ-specific autoantibodies in children with chronic hepatitis C virus infection.
Bogdanos DP; Mieli-Vergani G; Vergani D
Clin Infect Dis; 2004 May; 38(10):1505; author reply 1505-6. PubMed ID: 15156495
[No Abstract] [Full Text] [Related]
29. Visualizing hepatitis C virus infections in human liver by two-photon microscopy.
Liang Y; Shilagard T; Xiao SY; Snyder N; Lau D; Cicalese L; Weiss H; Vargas G; Lemon SM
Gastroenterology; 2009 Oct; 137(4):1448-58. PubMed ID: 19632233
[TBL] [Abstract][Full Text] [Related]
30. Serine protease inhibitors as anti-hepatitis C virus agents.
Reiser M; Timm J
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):537-47. PubMed ID: 19485794
[TBL] [Abstract][Full Text] [Related]
31. Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model.
Berinstein NL
Ann N Y Acad Sci; 2009 Sep; 1174():107-17. PubMed ID: 19769743
[TBL] [Abstract][Full Text] [Related]
32. Spontaneous clearance of chronic hepatitis C after liver transplantation: are hepatitis C virus-specific T cell responses the clue?
Suneetha PV; Mederacke I; Heim A; Bastürk M; Cornberg M; Strassburg CP; Manns MP; Wedemeyer H
Liver Transpl; 2008 Aug; 14(8):1225-7. PubMed ID: 18668659
[No Abstract] [Full Text] [Related]
33. Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.
Petta S; Cammà C; Di Marco V; Cabibi D; Ciminnisi S; Caldarella R; Licata A; Massenti MF; Marchesini G; Craxì A
Antivir Ther; 2009; 14(5):631-9. PubMed ID: 19704165
[TBL] [Abstract][Full Text] [Related]
34. Development of thyroid diseases in the treatment of chronic hepatitis C with alpha-interferon may be a good prognosticator in achieving a sustained virological response: a meta-analysis.
Tran HA; Malcolm Reeves GE; Gibson R; Attia JR
J Gastroenterol Hepatol; 2009 Jul; 24(7):1163-8. PubMed ID: 19682190
[TBL] [Abstract][Full Text] [Related]
35. [PD-1 up-regulation influenced apoptosis of HBV-specific CD8 T cells in patients with acute resolved hepatitis B].
Xu B; Zhang Z; Shi Y; Chen XY; Wang FS
Zhonghua Yi Xue Za Zhi; 2009 May; 89(17):1158-61. PubMed ID: 19595077
[TBL] [Abstract][Full Text] [Related]
36. Liver distribution of gammadelta-T-cells in patients with chronic hepatitis of different etiology.
Kasper HU; Ligum D; Cucus J; Stippel DL; Dienes HP; Drebber U
APMIS; 2009 Nov; 117(11):779-85. PubMed ID: 19845527
[TBL] [Abstract][Full Text] [Related]
37. Altered innate immunity in chronic hepatitis C infection: cause or effect?
Szabo G; Chang S; Dolganiuc A
Hepatology; 2007 Oct; 46(4):1279-90. PubMed ID: 17886338
[No Abstract] [Full Text] [Related]
38. Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide.
Pozo D; Anderson P; Gonzalez-Rey E
J Immunol; 2009 Oct; 183(7):4346-59. PubMed ID: 19734220
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic human papillomavirus vaccination.
Albers AE; Kaufmann AM
Public Health Genomics; 2009; 12(5-6):331-42. PubMed ID: 19684445
[TBL] [Abstract][Full Text] [Related]
40. In vitro activation and differentiation of naïve CD4+ and CD8+ T cells into HCV core- and NS3-specific armed effector cells: a new role for CD4+ T cells.
Krishnadas DK; Li W; Kumar R; Tyrrell LJ; Agrawal B
Cell Immunol; 2009; 259(2):141-9. PubMed ID: 19616202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
